Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Immuneering Corp (IMRX)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 25,940,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Immuneering is focused on improving patient outcomes by improving a pipeline of oncology and neuroscience product candidates developed using Co.'s translational bioinformatics platform. Co.'s development programs in oncology is focused on providing treatments for patients with solid tumors caused by mutations of the MAPK pathway and mTOR pathways. Co.'s primary product candidate, IMM-1-104, is designed to be a selective dual-mitogen-activated protein kinase kinase inhibitor that further disrupts kinase suppressor of RAS 1 and 2 to modulate the signaling dynamics of the MAPK pathway. In addition to IMM-1-104, Co. has six other oncology programs in the discovery stage.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 22,120 149,627 346,710
Total Buy Value $0 $152,641 $486,700 $964,655
Total People Bought 0 4 9 10
Total Buy Transactions 0 6 18 29
Total Shares Sold 0 0 0 1,309,091
Total Sell Value $0 $0 $0 $3,909,184
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 3
End Date 2025-10-16 2025-07-15 2025-01-14 2024-01-15

   
Records found: 78
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Feinberg Peter Director   –       •      –    2026-01-12 4 B $4.35 $86,904 I/I 20,000 135,441 2.1     -
   Feinberg Peter Director   –       •      –    2025-10-03 4 B $6.67 $50,025 D/D 7,500 156,766 2.39     -
   Morales Mallory Chief Accounting Officer   •       –      –    2025-10-01 4 B $6.39 $1,917 D/D 300 27,533 2.66     -
   Neufeld Leah R CHIEF PEOPLE OFFICER   •       –      –    2025-10-01 4 B $6.38 $5,103 D/D 800 23,344 2.74     -
   Bookman Michael CHIEF LEGAL OFFICER, SECRETARY   •       –      –    2025-10-01 4 B $6.83 $6,966 D/D 1,020 4,870 2.74     -
   Feinberg Peter Director   –       •      –    2025-09-30 4 B $7.03 $52,730 D/D 7,500 149,266 2.39     -
   Feinberg Peter Director   –       •      –    2025-09-29 4 B $7.18 $35,900 D/D 5,000 141,766 2.39     -
   Morales Mallory Chief Accounting Officer   •       –      –    2025-09-15 4 A $1.43 $20,702 D/D 14,497 27,233     -
   Hall Brett Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2025-09-15 4 A $1.43 $21,249 D/D 14,880 374,198     -
   Neufeld Leah R CHIEF PEOPLE OFFICER   •       –      –    2025-09-15 4 A $1.43 $16,872 D/D 11,815 22,544     -
   Hausman Diane Director   –       •      –    2025-07-02 4 B $3.62 $10,874 I/I 3,000 3,000 2.1     -
   Hausman Diane Director   –       •      –    2025-07-02 4 B $3.60 $8,989 D/D 2,500 2,500 2.39     -
   Neufeld Leah R CHIEF PEOPLE OFFICER   •       –      –    2025-07-02 4 B $3.57 $2,499 D/D 700 10,729 2.66     -
   Zeskind Benjamin J. PRESIDENT AND CEO   •       •       •   2025-07-02 4 B $3.53 $24,792 D/D 7,015 2,312,852 3.15     -
   Zeskind Benjamin J. PRESIDENT AND CEO   •       •       •   2025-07-01 4 B $3.38 $10,087 D/D 2,985 2,305,837 3.15     -
   Schall Thomas J. Director   –       •      –    2025-06-27 4 B $3.66 $34,788 D/D 9,500 52,885 2.39     -
   Hall Brett Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2025-06-23 4 B $2.43 $14,596 D/D 6,007 359,318 2.74     -
   Brakewood Harold Eugene Chief Business Officer   •       –      –    2025-06-20 4 B $2.53 $4,804 D/D 1,900 5,800 2.66     -
   Hall Brett Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2025-06-20 4 B $2.70 $20,020 D/D 7,415 353,311 2.74     -
   Feinberg Peter Director   –       •      –    2025-06-18 4 B $2.53 $63,188 D/D 25,000 136,766 2.39     -
   Zeskind Benjamin J. PRESIDENT AND CEO   •       •       •   2025-06-18 4 B $2.39 $50,144 D/D 21,000 2,302,852 3.23     -
   Schall Thomas J. Director   –       •      –    2025-06-17 4 B $2.21 $89,278 D/D 40,485 43,385 2.39     -
   Morales Mallory Chief Accounting Officer   •       –      –    2024-09-15 4 A $1.62 $7,238 D/D 4,458 12,736     -
   Cormorant Private Healthcare Fund Iii Lp   •       •       •   2024-04-01 4 S $2.90 $1,160,181 I/I (400,000) 2,895,273     -
   Brakewood Harold Eugene Chief Business Officer   •       –      –    2024-03-22 4 B $2.57 $10,015 D/D 3,900 3,900 2.74     -
  78 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2026 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us